Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 568 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Bluejay Diagnostics, Inc.
Market Cap
$833048.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$880673.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-23.42%
Market Cap
$893920.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$874595.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$685794.00
Net Profit Margin
6.30%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.02M
Net Profit Margin
-11314.24%
TTM Avg
-197362.53%
3Y Avg
-98681.26%
5Y Avg
-78945.01%
Market Cap
$566655.00
Net Profit Margin
-73.22%
TTM Avg
-7923.42%
3Y Avg
-4237.01%
5Y Avg
-2848.17%
Market Cap
$1.08M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.11M
Net Profit Margin
-8.46%
TTM Avg
-4.30%
3Y Avg
1.83%
5Y Avg
1.83%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | $833048.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Decoy Therapeutics Inc. (DCOY)vs › | $880673.00 | 0.00% | 0.00% | 0.00% | -23.42% |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $874595.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| CDT Equity Inc. (CDT)vs › | $685794.00 | 6.30% | 0.00% | 0.00% | 0.00% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -11314.24% | -197362.53% | -98681.26% | -78945.01% |
| HCW Biologics Inc. (HCWB)vs › | $566655.00 | -73.22% | -7923.42% | -4237.01% | -2848.17% |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | -8.46% | -4.30% | 1.83% | 1.83% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.16M | -14220.12% | -19831.38% | -10446.98% | -7103.54% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -777.95% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
